Saksoft Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:13 pm

Quick Insight

Saksoft Ltd, a player in the IT Consulting & Software industry, currently trades at a price of 215 with a market capitalization of 2,850 Cr., sporting a P/E ratio of 24.7. The company exhibits a robust Return on Equity (ROE) of 18.9% and Return on Capital Employed (ROCE) of 24.0%, indicating efficient capital allocation. With an Operating Profit Margin (OPM) of 18% and a Net Profit of 109 Cr., Saksoft demonstrates sound operational performance. However, the firm's high Price-to-Book Value (P/BV) ratio of 3.02x suggests a premium valuation. With a comfortable Interest Coverage Ratio (ICR) of 19.20x and a Current Ratio of 80 days, Saksoft appears financially stable. Despite the lack of specific shareholder information, the company's healthy reserves of 606 Cr. provide a cushion for growth and innovation. In conclusion, while Saksoft showcases strong financial metrics and operational efficiency, investors may want to consider the premium valuation indicated by the P/BV ratio before making investment decisions.

Competitors of Saksoft Ltd

All Competitor Stocks of Saksoft Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:15 am

Below is a detailed analysis of the quarterly data for Saksoft Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 249.00 Cr.. The value appears strong and on an upward trend. It has increased from 240.00 Cr. (Mar 2025) to 249.00 Cr., marking an increase of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 203.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 203.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 10.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 18.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 43.00 Cr., marking an increase of 6.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 25.00%, marking an increase of 6.00%.
• For Net Profit, as of Jun 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.44. The value appears strong and on an upward trend. It has increased from 2.27 (Mar 2025) to 2.44, marking an increase of 0.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:09 pm

Growth

Last Updated: September 5, 2025, 1:15 pm

Balance Sheet

Last Updated: June 16, 2025, 11:25 am

Below is a detailed analysis of the balance sheet data for Saksoft Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 606.00 Cr.. The value appears strong and on an upward trend. It has increased from 495.00 Cr. (Mar 2024) to 606.00 Cr., marking an increase of 111.00 Cr..
• For Borrowings, as of Mar 2025, the value is 75.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 26.00 Cr. (Mar 2024) to 75.00 Cr., marking an increase of 49.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 298.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 255.00 Cr. (Mar 2024) to 298.00 Cr., marking an increase of 43.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 993.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 786.00 Cr. (Mar 2024) to 993.00 Cr., marking an increase of 207.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 520.00 Cr.. The value appears strong and on an upward trend. It has increased from 357.00 Cr. (Mar 2024) to 520.00 Cr., marking an increase of 163.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 14.00 Cr..
• For Other Assets, as of Mar 2025, the value is 472.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Mar 2024) to 472.00 Cr., marking an increase of 57.00 Cr..
• For Total Assets, as of Mar 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 786.00 Cr. (Mar 2024) to 993.00 Cr., marking an increase of 207.00 Cr..

Notably, the Reserves (606.00 Cr.) exceed the Borrowings (75.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Saksoft Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 9.59 (Mar 24) to 8.21, marking a decrease of 1.38.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has decreased from 9.11 (Mar 24) to 8.21, marking a decrease of 0.90.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.55. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.55, marking a decrease of 1.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.70. It has decreased from 50.18 (Mar 24) to 48.70, marking a decrease of 1.48.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.70. It has decreased from 50.18 (Mar 24) to 48.70, marking a decrease of 1.48.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 69.46. It has decreased from 75.61 (Mar 24) to 69.46, marking a decrease of 6.15.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 12.83. This value is within the healthy range. It has decreased from 14.26 (Mar 24) to 12.83, marking a decrease of 1.43.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.84. This value is within the healthy range. It has decreased from 13.08 (Mar 24) to 11.84, marking a decrease of 1.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.17. This value is within the healthy range. It has decreased from 12.73 (Mar 24) to 11.17, marking a decrease of 1.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has decreased from 9.55 (Mar 24) to 8.56, marking a decrease of 0.99.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has decreased from 9.55 (Mar 24) to 8.56, marking a decrease of 0.99.
• For PBDIT Margin (%), as of Mar 25, the value is 18.46. This value is within the healthy range. It has decreased from 18.85 (Mar 24) to 18.46, marking a decrease of 0.39.
• For PBIT Margin (%), as of Mar 25, the value is 17.03. This value is within the healthy range. It has decreased from 17.29 (Mar 24) to 17.03, marking a decrease of 0.26.
• For PBT Margin (%), as of Mar 25, the value is 16.07. This value is within the healthy range. It has decreased from 16.83 (Mar 24) to 16.07, marking a decrease of 0.76.
• For Net Profit Margin (%), as of Mar 25, the value is 12.32. This value exceeds the healthy maximum of 10. It has decreased from 12.62 (Mar 24) to 12.32, marking a decrease of 0.30.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.32. This value is within the healthy range. It has decreased from 12.62 (Mar 24) to 12.32, marking a decrease of 0.30.
• For Return on Networth / Equity (%), as of Mar 25, the value is 17.57. This value is within the healthy range. It has decreased from 19.02 (Mar 24) to 17.57, marking a decrease of 1.45.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.75. This value is within the healthy range. It has decreased from 23.09 (Mar 24) to 20.75, marking a decrease of 2.34.
• For Return On Assets (%), as of Mar 25, the value is 10.95. This value is within the healthy range. It has decreased from 12.22 (Mar 24) to 10.95, marking a decrease of 1.27.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.08, marking an increase of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.99. It has decreased from 1.12 (Mar 24) to 0.99, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 1.94 (Mar 24) to 1.68, marking a decrease of 0.26.
• For Quick Ratio (X), as of Mar 25, the value is 1.68. This value is within the healthy range. It has decreased from 1.94 (Mar 24) to 1.68, marking a decrease of 0.26.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.84 (Mar 24) to 0.00, marking a decrease of 7.84.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.97 (Mar 24) to 0.00, marking a decrease of 6.97.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.16 (Mar 24) to 0.00, marking a decrease of 92.16.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.03 (Mar 24) to 0.00, marking a decrease of 93.03.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 19.20. This value is within the healthy range. It has decreased from 40.74 (Mar 24) to 19.20, marking a decrease of 21.54.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 13.81. This value is within the healthy range. It has decreased from 28.28 (Mar 24) to 13.81, marking a decrease of 14.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,804.81. It has decreased from 2,382.43 (Mar 24) to 1,804.81, marking a decrease of 577.62.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.95. This value is within the healthy range. It has decreased from 3.13 (Mar 24) to 1.95, marking a decrease of 1.18.
• For EV / EBITDA (X), as of Mar 25, the value is 10.58. This value is within the healthy range. It has decreased from 16.59 (Mar 24) to 10.58, marking a decrease of 6.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.12, marking a decrease of 1.25.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 92.15 (Mar 24) to 0.00, marking a decrease of 92.15.
• For Price / BV (X), as of Mar 25, the value is 3.02. This value exceeds the healthy maximum of 3. It has decreased from 5.08 (Mar 24) to 3.02, marking a decrease of 2.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.12, marking a decrease of 1.25.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness